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ABSTRACT
The PcrA/UvrD helicase functions in multiple path-
ways that promote bacterial genome stability includ-
ing the suppression of conflicts between replication
and transcription and facilitating the repair of tran-
scribed DNA. The reported ability of PcrA/UvrD to
bind and backtrack RNA polymerase (1,2) might be
relevant to these functions, but the structural ba-
sis for this activity is poorly understood. In this
work, we define a minimal RNA polymerase inter-
action domain in PcrA, and report its crystal struc-
ture at 1.5 A˚ resolution. The domain adopts a Tudor-
like fold that is similar to other RNA polymerase in-
teraction domains, including that of the prototype
transcription-repair coupling factor Mfd. Removal or
mutation of the interaction domain reduces the abil-
ity of PcrA/UvrD to interact with and to remodel
RNA polymerase complexes in vitro. The implica-
tions of this work for our understanding of the role of
PcrA/UvrD at the interface of DNA replication, tran-
scription and repair are discussed.
INTRODUCTION
Helicases are ubiquitous, abundant and diverse enzymes
playing a wide variety of different roles in cellular nu-
cleic acid metabolism (3). Several superfamilies (SF) of
these enzymes have been described on the basis of primary
structure and SFI and II, which are non-hexameric heli-
cases, are by far the largest groups (4). Bacterial cells typ-
ically encode several SFI enzymes that function in differ-
ent genome replication, maintenance and expression path-
ways (5). Structural studies have shown that SFI enzymes
share highly conserved core helicase domains responsi-
ble for ATP-dependent DNA translocation and unwind-
ing, and that their targeting to different pathways is often
achieved via the modular addition of different specificity
domains, either flanking or inserted within the core helicase
domains (6).
An interesting example is provided by the UvrD heli-
case (also annotated Helicase II, or PcrA in many Gram
positive bacteria including Bacillus subtilis) which has been
implicated in nucleotide excision repair (NER), mismatch
repair, homologous recombination and rolling circle repli-
cation mechanisms (7–13). This multi-functionality is re-
flected in the ability of UvrD/PcrA to interact physically
and functionally with many different partner proteins in-
cluding UvrB, MutL, MutS, RecA and RepC/D (13–20).
We and others have recently shown that PcrA/UvrD also
interacts with RNA polymerase (RNAP) (1,14,21), and this
interaction could be important for the UvrD-dependent
backtracking of stalled RNA polymerase (1). It was sug-
gested that this activity helps to recruit the NERmachinery
to sites of UV damage, acting as an alternative pathway of
transcription-coupled repair (TCR) in addition to the well-
characterized Mfd pathway (for reviews see (22–25)). This
ability of UvrD to remodel RNAP-DNA complexes might
also be relevant to the ability of PcrA/UvrD to suppress
conflicts between replication and transcription, a property
it shares with the very closely related helicase Rep (although
Rep does not interact with RNAP) (26–28). The extreme C-
terminal region of PcrA/UvrD is important for interaction
with both RNAP (14,29) and UvrB (30). However, despite
its apparent role as a protein interaction hub that targets the
helicase to physiological substrates, there is no clear phe-
notype established for removal of the C-terminal domain
(CTD), and its structure has never been resolved. In thir-
teen structures of the PcrA/UvrD protein from various or-
ganisms, this region of the protein was either removed to
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aid crystallization or is disordered in the final model (31–
36) (Supplementary Figure S1).
In this report, we define a small folded RNA polymerase
interaction domain in Geobacillus stearothermophilus PcrA
and have solved its structure at high resolution. Based on
its similarity to other Tudor-like domains, we identify con-
served residues on its surface that are likely to be directly
involved in the interaction with RNAP. Mutation of these
residues, or the complete removal of the interaction do-
main, substantially reduces the ability of PcrA/UvrD to
bind to RNAP and to remodel transcription elongation
complexes in vitro.
MATERIALS AND METHODS
Protein expression and purification
His-tagged Escherichia coli RNAP holoenzyme was pu-
rified as described (37). GreB protein was a gift from
Terence Strick. Purified ParB protein was a gift from
James Taylor. Biotinylated BSA protein was purchased
from ThermoScientific. UvrD and UvrDK708A were puri-
fied from BL21(DE3) cells transformed with pETDUET-
UvrD (15) or pETDUET-UvrDK708A, which was made
from pETDUET-UvrD by site directed mutagenesis. Cells
were grown at 37◦C to an A600 of ∼0.5 before being used
to inoculate 1 l of LB + 100 g/ml ampicillin to an A600 of
∼0.025. When cells reached an A600 of 0.2 they were trans-
ferred to 18◦Candwhen theA600 reached∼0.5, 1mMIPTG
was added to induce protein expression. Cultures were then
grown overnight at 18◦C and the cells were harvested by
centrifugation at 4◦C. The cell pellet was resuspended in 20
ml of lysis buffer (20 mM Tris–HCl pH 8.3, 10% (v/v) glyc-
erol, 200 mM NaCl, 5 mM EDTA pH 8.0, 0.5 mM EGTA
pH 8.0, 1 mM DTT) containing 4 mg of lysozyme and in-
cubated on ice for 30 min. 250 l 4% sodium deoxycholate
was added and cells were then incubated on ice for another
30 min. To increase the UvrD solubility, NaCl concentra-
tion was increased to∼450 mMby adding 1.2 ml 5MNaCl
and stirring for 15 min at 4◦C. The cells were lysed by son-
ication and the soluble fraction was recovered by centrifu-
gation. In order to precipitate the UvrD, saturated ammo-
nium sulphate was added gradually to the supernatant un-
til 30% saturation was reached. The protein was allowed to
precipitate for 1 h in an ice waterbath and was recovered by
centrifugation at 4000 rpm for 30 min. The pellet was resus-
pended in buffer (20 mM Tris–HCl pH 8.3, 20% (v/v) glyc-
erol, 400 mM NaCl, 2 mM EDTA pH 8.0, 0.5 mM EGTA
pH 8.0, 1 mM DTT) and was slowly diluted in buffer A
(20 mMTris–HCl pH 8.3, 20% (v/v) glycerol, 1 mMEDTA
pH 8.0, 0.5 mM EGTA pH 8.0 and 1 mM DTT) until the
salt concentrationwas approximately 200mMNaCl (or 100
mM for the UvrDK708A mutant). This was then loaded onto
a 5 ml Heparin column (GE) on an A¨KTA FPLC. The
protein was eluted from the column using a NaCl gradi-
ent in buffer A. Fractions containing the protein of interest
were combined and diluted in buffer A until the salt con-
centration was approximately 200 mM NaCl (or 100 mM
for the UvrDK708A mutant). Protein was loaded onto a 1
ml MonoQ column (GE) on an A¨KTA FPLC. The pro-
tein was eluted using a NaCl gradient in buffer A. Fractions
containing only the protein of interest were dialysed at 4◦C
overnight against storage buffer (20 mM Tris–HCl pH 8.3,
200 mMKCl, 1 mM EDTA pH 8.0, 2 mMDTT, 20% (v/v)
glycerol). UvrDCwas purified fromBL21DE3 cells trans-
formed with pETDUET-UvrD1–647 as described (15).
Biotinylated PcrA and biotinylated PcrA-Ct (including
residues 653–724 of the native protein) were produced using
vectors and purification protocols that have been described
previously (14). An equivalent vector for expression of bi-
otinylated PcrA-sCt was created by deleting a short region
of the PcrA-Ct construct. This yielded a vector for overex-
pression of the extreme C-terminal region of PcrA (residues
673–724) fused to an N-terminal AviTag sequence (MSG
LND IFE AQK* IEWHEGGG; the asterisk indicates the
biotinylated lysine). This protein was overexpressed and pu-
rified using the same method as for the PcrA-Ct construct.
Constructs for the expression of the histidine-tagged PcrA
C-terminus were produced by cloning synthetic DNA (In-
vitrogen) into the pET47b vector (Novagen). The PcrA-
Ct construct expresses a protein with an N-terminal hexa-
histidine tag fused via a 3C cleavable linker to residues 653–
724 of Geobacillus stearothermophilus PcrA. The sequence
of the tag is MAH HHH HHS AAL EVL FQG *PGG
G where the asterisk indicates the position of 3C cleavage.
The PcrA-sCt construct only codes for residues 673–724
of the native PcrA protein, but is otherwise equivalent to
PcrA-Ct. Point mutations were made in all of the above vec-
tors using the QuikChange II kit (Invitrogen) and the con-
structs were verified by DNA sequencing (Sequencing ser-
vice, University of Dundee). His-tagged PcrA-Ct and his-
tagged PcrA-sCt were overexpressed in BL21(DE3) with
appropriate antibiotics and harvested using the same pro-
tocol as for full-length PcrA (14). Following sonication,
the proteins were bound to a 5 ml HisTrap column (GE
Healthcare) in a buffer containing 50 mM Tris–Cl, pH7.5
and 200 mM NaCl, and eluted over a 20–500 mM imida-
zole gradient. Where appropriate, the his-tag was removed
with HRV 3C protease overnight at 4◦C (ThermoScientific,
manufacturer’s instructions) while dialysing against a buffer
containing 50 mM Tris–Cl, pH7.5, 1 mM EDTA, 200 mM
NaCl and 20 mM imidazole. The cleaved protein was re-
passed over the HisTrap column to remove HRV 3C pro-
tease contamination and PcrA S-Ct was collected in the
flow-through. The cleaved (or uncleaved) protein was fi-
nally purified using a Superdex75 gel filtration column (GE
Healthcare) in a buffer containing 50 mMTris–Cl, pH7.5, 1
mMEDTA, 1 mMDTT and 200 mMNaCl. Peak fractions
were pooled and concentrated using a 3 kDa cut-off spin
concentration device.Where appropriate, removal of the tag
was verified by separation using a 10–20% Tris–tricine gel
by comparison with the his-tagged protein. The concentra-
tion of protein was determined by spectrophotometry us-
ing a theoretical extinction coefficient of 11 000 M−1 cm−1.
The protein was snap frozen and stored at –80◦C in a buffer
containing 50 mM Tris–Cl, pH7.5, 1 mM EDTA, 200 mM
NaCl, 1 mM DTT and 10% glycerol.
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Crystallization, structure determination and structure analy-
sis
The PcrA-sCt protein (with the his-tagged removed) was
concentrated to 20 mg/ml in a buffer of 50 mM Tris-Cl
(pH 7.5), 1 mM EDTA, 200 mM NaCl and 10% glycerol.
Crystals were grown using the sitting-drop vapor diffusion
method at 18◦C by mixing 0.2 l protein solution with 0.2
l precipitant solution containing 3.5 M sodium formate
pH7.0. Crystals were harvested and frozen using the precip-
itant solution. A mercury derivative was prepared by soak-
ing the crystals for 4 h in cryosolution (3.5 M sodium for-
mate pH 7.0) containing 10 mM ethyl mercury phosphate,
and then freezing. X-ray diffraction data were collected at
100 K using a Rigaku FR-X X-ray generator and PILA-
TUS 300K detector. The data were processed and scaled
using the HKL3000R program (38). A single mercury site
was found by directmethods in SHELXD (39).Heavy-atom
refinement and phasing (using SIRAS) were performed us-
ing SHARP (40). Solvent flipping and density modification
were performed using SOLOMON (41) and Parrot (42), re-
spectively. An initial model was built automatically using
Buccaneer (43) and the final structure model was manually
rebuilt using Coot (44) with refinement in Refmac (45) and
Phenix (46). Diffraction data and refinement statistics are
listed in Table 1, and the co-ordinates of the structure have
been deposited at the PDB under ID code 5DMA. Figures
showing the conservation of residues in PcrA mapped onto
the structure were created using ConSurf (47) and PyMOL.
The multiple sequence alignment was based on 150 unique
sequences that were the most similar to the G. stearother-
mophilus PcrA C-terminus using the ConSurf default input
settings.
Pulldown assays
Pulldown assays were performed as in previous work (14)
using either streptavidin-coated magnetic beads (New Eng-
land Biolabs) for biotin-tagged bait proteins or substitut-
ing Ni2+-NTA magnetic beads (New England Biolabs) for
his-tagged bait proteins. Briefly, DNA/RNA-depleted ex-
tracts of B. subtilis 168 were produced as described previ-
ously (14). B. subtilis was chosen as the source for the bait
proteins because the PcrA from this organism is highly simi-
lar (85%) to its orthologue from G. stearothermophilus, and
because the annotated proteome is important for the pro-
teomics analysis (below). Nevertheless, it should be noted
that our pulldown experiments may be susceptible to false
negatives because of the different Bacillaceae species used
for bait and prey proteins. The prepared extracts were then
used as the prey in pulldown experiments. Purified bait pro-
teins were incubated at near saturating concentrations with
magnetic beads to allow binding. The baited beads were
washed and added to B. subtilis cell extracts to allow bind-
ing with partner proteins. The beads were separated from
the cell extract and washed before bait and prey proteins
were harvested from the beads by boiling in SDS-PAGE
sample buffer. The pulldown experiments were analysed
by SDS-PAGE followed by either western blotting with an
anti-RNAP  antibody (8RB13, Abcam (48)), or by mass
spectrometry. Details of sample preparation for mass spec-
trometry can be found in the Supplementary Information.
Construction of templates for in vitro transcription assays
Linear DNA templates for in vitro transcription reactions
were constructed by PCR amplification from pSRT7A1
(49) using Pfu DNA polymerase. Templates containing the
T7A1 promoter were amplified using the upstream primer
5′-ACCTGACGTCTAAGAAACC-3′ and the downstream
primer 5′-ATTACTGGAGGGGATGGGG-3′ to produce
a 236 bp product. On this template transcription can be
stalled by nucleotide starvation at +20 by omitting UTP.
Transcription can also be chased to the template end to pro-
duce a transcript of 60 nt. Linear biotinylated DNA tem-
plate was made in a similar manner using a 5′-biotinylated
upstream primer and DNA templates were purified us-
ing the QIAEX II DNA extraction kit (Qiagen). Plasmid
pSRTB8B3+500 was created by inserting a 504 bp frag-
ment amplified from theE. coli rpoB gene between the NcoI
and XhoI sites located between the T7A1 promoter and
the tandemly repeated BbvCI sites of pSRTB8B3 (50). On
the resulting template transcription from the T7 promoter
can be stalled at +20 by UTP starvation, or allowed to
run to a downstream terminator to produce a 764 nt tran-
script. A biotinylated closed-circular plasmid template car-
rying a biotin-dT at position +585 on the transcribed strand
was generated by annealing a biotin-dT-containing oligonu-
cleotide into BbvCI-nicked plasmid pSRTB8B3+500, as de-
scribed in (50).
In vitro transcription time course and transcript release as-
says
For time course assays, transcription initiation complexes
were formed by incubating 20 nM E. coli RNA polymerase
holoenzyme with 2 ng/l DNA template for 5 min at 37◦C
in repair buffer (40 mM HEPES, pH 8.0, 100 mM KCl,
8 mM MgCl2, 4% glycerol (v/v), 5 mM DTT, 100 g/ml
BSA). Transcription elongation complexes stalled at +20
were then formed by nucleotide starvation: the preformed
transcription initiation complexes weremixed with an equal
volume of NTP stall mix in repair buffer (final concentra-
tions 100 M ApU, 10 M ATP, 10 M GTP, 2 M CTP,
0.5 Ci/l [-32P] CTP) and incubated for 5 min at 37◦C.
Aliquots of the stalled elongation complexeswere incubated
with UvrD or its derivatives at the concentrations indicated
for 5 min at 37◦C. Transcription elongation was then al-
lowed to continue for 5 min at 37◦C by adding a ‘chase’ of
100MNTPs, togetherwith 10g/ml rifamipicin to ensure
that only a single round of transcription took place. Reac-
tions were stopped with an equal volume of urea stop mix
(7 M urea, 10 mM EDTA, 1% SDS, 2× TBE, 0.05% bro-
mophenol blue, 0.05% xylene cyanol). Samples were heated
for 3 min at 90◦C and resolved on a 15% polyacrylamide/7
M urea denaturing gel. Gels were analyzed using aMolecu-
lar Dynamics Typhoon PhosphorImager and ImageQuant
software. For comparison of RNAP remodeling activity as
shown in Figure 5, the data were normalized across multi-
ple gels by determining the total intensity of the remodeling
products for any given protein at any given timepoint (see
black bar in Figure 5A) and dividing this value by the high-
est value observed for the wild type activity on each gel (typ-
ically the final timepoint). This value therefore represents a
relative remodeling activity compared tomaximal wild-type
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Table 1. X-ray data collection and refinement statistics for PcrA-sCt
Hg Native
Data collection statistics
Wavelength (A˚) 1.54 1.54
Space group P3221 P3221
Cell dimensions (a, b, c) (A˚) 50.4, 50.4, 40.4 50.5, 50.5, 40.2
Resolution (A˚) 50–1.7 (1.8–1.7)a 50–1.5 (1.6–1.5)a
Observed/unique reflections 41 952/6980 92 776/9252
Data redundancy 6.0 (3.0) 10.0 (5.1)
Completeness (%) 99.3 (98.7) 99.9 (98.9)
Rsym (%) 7.5 (15.8) 3.4 (18.5)
I/(I) 33.6 (8.1) 61.6 (7.7)
Refinement statistics
Resolution range (A˚) 30.0–1.5
Reflections (work/test) 9167/438
Rwork/Rfree (%) 19.5/22.2
Number of atoms (protein/water) 407/65
Average B-factor (protein/solvent) (A˚2) 15.2/25.5
RMSD in bond length (A˚)/bond angle (◦) 0.007/1.193
aValues in parentheses refer to the highest resolution shell.
activity. The error bars represent the standard error of the
mean for wild type (six experiments) or mutant UvrD (four
experiments each) respectively.
For transcript release assays, stalled transcription elonga-
tion complexes were formed as described above, but using
biotinylated template DNA. DNA containing the stalled
complexes was bound to streptavidin paramagnetic beads
(NEB) by incubating each reaction with beads taken from
an equal volume of bead suspension (and washed twice
with repair buffer) for 10 min at 20◦C. The beads were then
washed three times in equal volumes of repair buffer to re-
move unbound DNA and RNAP. 1 MUvrD or UvrDC
was added to 20 l aliquots of the reaction where indicated
and reactions were incubated for 5 min at 37◦C. Transcrip-
tion reactions were chased by adding 100 MNTPs and 10
g/ml rifamipicin for 5 min at 37◦C. A magnet was used
to separate pellet and supernatant fractions and the super-
natant was added to 20 l urea stop mix (fraction S). The
pellet was resuspended in 20 l repair buffer and added to
20 l urea stop mix (fraction P).
For transcript-release experiments in which backtracking
was analyzed with GreB, reaction volumes were scaled up
and 1 M UvrD or its derivatives were added to 100 l
aliquots containing stalled transcription elongation com-
plexes. Transcription reactions were chased as described
above. A magnet was used to separate pellet and super-
natant fractions and 20 l of the supernatant was added
to 20 l urea stop mix (fraction S). The beads were re-
suspended in 80 l repair buffer and a 20 l sample was
added to 20 l urea stop mix (fraction P). The remainder
of the bead suspension was split into 20 l aliquots. 1 M
GreB was added where indicated and reactions were incu-
bated for 5 min at 37◦C. Then 100 M NTPs were added
where indicated and reactions were incubated for 5 min at
37◦C. Reactions were stopped with 20 l urea stop mix.
Samples were heated for 3 min at 90◦C and resolved on a
15% polyacrylamide/7 M urea denaturing gel. Gels were
analysed using a Molecular Dynamics Typhoon in Phos-
phorImager mode and ImageQuant software.
ATPase assays
The ATPase activity of UvrD and its derivatives was mea-
sured using an enzyme linked assay in which ATP hydrol-
ysis is coupled to NADH oxidation essentially as reported
previously (51). However, ATPase assays were modified in
that reactions were carried out at 37◦C using 1 nM UvrD,
2 mM ATP and 2 M ssDNA (47 nt). The ATPase activ-
ity of PcrA and its derivatives was measured using the same
linked assay, according to the method described in (34).
TFO displacement (DNA translocase) assays
TFO assays were carried out essentially as described in
(49). Assays were carried out on a linear plasmid tem-
plate, pSRTB2EV, a derivative of pSRTB2 (50), in which an
EcoRV site had been introduced downstream of the TFO
binding site by site-directed mutagenesis. This template was
linearised by EcoRV, creating a blunt end 33 bp downstream
of the triplex end. Assays were performed in repair buffer
and the TFO containing DNA template was incubated with
1 M UvrD or its derivatives and 100 M NTP mix. 0.25
mg/ml Proteinase K and 10 mM CaCl2 were added to the
GSMB stop buffer and reactions were incubated for 30 min
at 20◦C before loading onto the gel to eliminate bandshift-
ing by UvrD.
RESULTS
Structure of a Tudor-like RNA polymerase interaction do-
main in PcrA
We have shown previously that the CTD of G. stearother-
mophilusPcrA (PcrA-Ct; residues 653–724) is necessary and
sufficient for interaction with RNA polymerase using affin-
ity pulldown assays from extracts of B. subtilis (14) (see
Supplementary Figure S1). Secondary structure predictions
using Jpred (52) suggested that this region of the protein
includes a significant region of natively disordered protein
that is poorly conserved. However, this is followed by a very
highly conserved region that is predicted to consist entirely
of beta-sheet (residues 673–724). Furthermore, the domain
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identification algorithms Ginzu (53) and Phyre2 (54) both
predict that this beta-sheet region will fold into a Tudor-
like domain. Despite very low primary structure homology,
these algorithms identify RapA and CarD respectively as
templates for homology modelling. Interestingly, these are
both bacterial RNAP interaction partners containing con-
served Tudor-like domains (55,56). Therefore, we hypoth-
esized that the extreme C-terminus of PcrA adopts a Tu-
dor fold and that this interacts directly with RNAP. To test
this idea, we designed a new shorter version of the PcrA
CTD using the homology models as a guide. This con-
struct, which we call PcrA-short Ct (PcrA-sCt), includes
residues 673–724 of the native PcrA protein. Moreover, to
produce the CTD of PcrA in greater quantities than we had
achieved previously using a biotin-tag (14), we engineered
plasmids for expression of PcrA-Ct and PcrA-sCt with a
cleavable histidine tag at the N-terminus. Using this system,
we were able to obtain large amounts of highly pure pro-
tein either with or without the tag (Supplementary Figure
S2). To confirm that the shorter CTD construct retained
the ability to interact with RNAP, we performed affinity
pulldown experiments using the his-tagged PcrA-sCt pro-
tein as bait and nucleic acid-depleted cell extracts as prey
(14). As expected, the original PcrA-Ct construct efficiently
pulled down RNAP from a B. subtilis extract in a dose-
dependent manner. In agreement with our hypothesis, the
shorter PcrA-sCt construct retained the ability to pulldown
RNAP, and the efficiency was comparable to PcrA-Ct (Sup-
plementary Figure S2). For reasons that will be discussed
below, we also investigated whether the PcrA CTDwas able
to bind to DNA.However, no interaction between the PcrA
CTD and either single- or double-stranded DNA was de-
tected using gel shift assays (Supplementary Figure S3).
Crystals of PcrA-sCt (with the histidine tag removed)
were obtained using the sitting drop vapor diffusion
method. The structure was solved using a heavy atom
derivative at a final resolution of 1.5 A˚ (Rfree = 22.2%) (Fig-
ure 1). The final model includes all of the residues of the
native PcrA sequence (W673 to V724) and an N-terminal
glycine from the tag linker region. As predicted, the extreme
C-terminal region of PcrA adopts a Tudor-like fold consist-
ing of five anti-parallel beta strands that form a twisted 
sheet. It closely resembles other bacterial Tudor domains
such as those found in RapA, CarD and Mfd (Figure 2)
(57–61). A search with DALI (62) also reveals strong simi-
larity to NusG (63) and to eukaryotic ‘histone readers’ in-
cluding PHF1 (64). These histone readers are responsible
for the recognition of methylated lysine residues in chro-
matin. Many structures of Tudor domains interacting with
their partner proteins or peptides have shown that one par-
ticular face of the fold is often responsible for the interac-
tion (65), although there are apparent exceptions including
RapA (59) (Figure 2). In histone readers, this face includes
an ‘aromatic cage’ that typically accepts the methylated side
chain of a lysine residue. Interestingly, some key residues
that form this aromatic cage appear to be equivalent in PcrA
(egW684, F705). However, PcrA also features a charged ly-
sine residue (K712) in this region. Although not common
for Tudor domains in general, this lysine residue is strongly
conserved within PcrA/UvrD orthologues (Figure 1D). We
were especially interested to compare our structure with the
complex of the Mfd Tudor domain bound to RNAP, be-
cause PcrA/UvrD has been reported to function in an al-
ternative TCR pathway (1). The structure of Thermus ther-
mophilus Mfd bound to RNAP shows that it binds to the
so-called1 region (60) and this is also true of the Tudor do-
main found inMycobacterium tuberculosisCarD (58,61). In
both of those structures, the Tudor domain forms a continu-
ous anti-parallel beta-sheet with the partner protein, which
is further stabilized by side-chain interactions. Conserved
residues that are important for interaction with RNAP in-
clude a lysine residue (K360 in T. thermophilusMfd) that is
somewhat similarly positioned to the aforementioned K712
in PcrA (57).However, it should be noted that there is no ap-
parent sequence homology between the Tudor-like domains
of PcrA and Mfd.
Conserved amino acids required for binding RNAP
Several highly conserved residues cluster together on the
surface of the PcrA Tudor fold that frequently forms a pro-
tein:protein interface in other systems (Figures 1 and 2).
We reasoned that these residues might be directly involved
in the interaction with RNA polymerase. To test this hy-
pothesis, we individually mutated several of them (H681A,
W684A, K712A and L714A) and tested the ability of the
resulting CTD constructs to interact with RNAP in pull-
down assays. The mutant PcrA-sCt proteins were purified
using the same method as for wild type and their CD spec-
tra were all characteristic of  sheet as expected, suggesting
normal global folding (SupplementaryFigure S4). The pull-
down assays revealed that each of the singlemutant proteins
had a severely reduced ability to bind toRNAP (Figure 1C).
Indeed, western blotting of the gels with an anti-RNAP sub-
unit antibody suggested the binding was marginally above a
‘no bait’ control and comparable to a second negative con-
trol experiment using B. subtilis ParB (a protein not known
to bind RNAP).
The K712A and L714A mutations were also made in the
context of a full length biotinylated PcrA construct used
in our previous studies. These mutant proteins displayed
a greatly reduced ability to interact with RNAP, but the
binding was reproducibly higher than background (Figure
3A).Moreover, as has been shown previously (14), the com-
plete deletion of the CTD from the full length protein dra-
matically reduces binding to RNAP. In order to validate
these experiments and to test for protein interactions of the
CTD in an unbiased fashion, we also analysed the pulldown
experiments using mass spectrometry. Relative quantifica-
tion of prey proteins was performed by comparing total
ion scores using the ‘no bait’ pulldown as a control (Fig-
ure 3B and Supplementary Table S1). The relative ion score
for the PcrA bait acts as an internal control, showing en-
richment over control for full length constructs, and a re-
duced enrichment for the PcrA-Ct construct as would be
expected based on the different polypeptide lengths. The re-
sults for the wild type PcrA bait reproduced our previously
published experiments showing that it interacts with many
proteins in the cell extract (see also (14) and Supplementary
Table S1 for full details). Prominently these include both
core and accessory subunits of RNA polymerase (, , ′,
, ), as well as a variety of sigma factors. Other enriched
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proteins of interest include YvgS/HelD (a SF1 helicase also
known to associate with RNAP), UvrB (a known PcrA
binding partner involved in NER), DNA pol I (a DNA re-
pair specific and bypass polymerase) and LigA (an NAD+-
dependent DNA ligase originating from the same operon
as PcrA) (Figure 3B). In good agreement with the western
blotting analysis, mass spectrometry showed that mutation
(K712A or L714A) or removal of the PcrA CTD substan-
tially reduced or almost eliminated the interaction with core
RNAP subunits respectively. These data show that the mu-
tated residues are critical for the RNAP binding function
of the CTD, and that the apparent residual binding we have
observed probably occurs at a different site in the PcrA pro-
tein. Interestingly, a concomitant reduction in several other
interaction partners including UvrB and YvgS was also de-
tected. This is consistent with two possibilities that can-
not be distinguished based on these experiments. Either the
CTD of PcrA is important for direct interaction with all of
these proteins, or the other proteins are associated with the
RNAP subunits that are pulled down by PcrA. In this re-
spect it should be noted that PcrA/UvrD interacts directly
with RNAP and UvrB (1,14,15), and that YvgS/HelD in-
teracts directly with RNAP (66). In distinct contrast, the
removal or mutation of the CTD of PcrA did not affect the
apparent interaction with DNA pol I or LigA, whereas the
CTD alone bound poorly to these proteins, showing that
they must interact mainly with the N-terminal region of
PcrA. Importantly, this observation confirms that the mu-
tant PcrA proteins remain largely folded, as would be ex-
pected based on CD analysis of the CTD variants alone
(see above). This assertion is further supported by analy-
sis of the DNA-dependent ATPase activity, which is similar
or slightly better than wild type for both mutant proteins
(Table 2).
The UvrD CTD is important for the remodeling of RNAP
transcripts
Due to differences in the manner in which it was discovered
in the model organisms B. subtilis and E. coli, the helicase
studied here is often annotated as PcrA in Gram-positive
organisms and UvrD in Gram–negative organisms. It was
therefore of considerable interest to us that E. coli UvrD
was recently shown to induce backtracking of RNAP in
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Figure 2. Comparison of Tudor-like domains and their interactions with partner proteins. (A) Structure of the CTD of PcrA (PDB: 5DMA; this work).
(B) Superimposition of the RNAP interaction domain of E. coli Mfd (cyan) (PDB: 2EYQ; (57)) with a complex between the Mfd RID (blue) and the
1 domain of RNAP polymerase (brown) (PDB: 3MLQ; (60)). (C) The complex of CarD (red) bound to the RNAP  subunit (brown) (PDB: 4KBM;
(58)). (D) Complex between the second Tudor domain of RapA (orange) and the ′ subunit of RNAP (blue) (PDB:4S20; (59)). (E) Complex between the
Tudor-like domain of NusG (green) and ribosomal protein S10 (yellow) (PDB:2KVQ; (63)). (F) The PHF1 protein (turquoise) in complex with a peptide
(white) shown in stick format and containing a trimethylated lysine residue (red) (PDB:4HCZ; (64)).
Table 2. ssDNA-dependent ATPase activity of PcrA and UvrD
Protein ATPase (s−1)a
Wild type PcrA 12.1 ± 0.8
PcrA K712A 15.8 ± 0.7
PcrA L714A 18.9 ± 1.8
Wild type UvrD 81.1 ± 3.0
UvrDC 194.9 ± 7.5
UvrD K708A 82.8± 19.8
aATP hydrolysis was measured using a coupled assay as described in the
Materials and Methods under conditions of saturating ATP and ssDNA.
The values reported are the mean turnover number and the standard error
of the mean for three independent experiments.
vitro, causing it to slide backwards on the DNA and bring-
ing about the displacement of the 3′ end of the RNA from
the active site (1). To reproduce this activity and to probe
the potential role of the CTD, in vitro transcription reac-
tions were performed in which wild type or mutant UvrD
was incubated withRNAP (both fromE. coli) that had been
stalled 20 nt downstreamof theT7A1promoter by omission
of UTP. The reaction was then ‘chased’ with NTPs, and ri-
fampicin was added to ensure single round conditions.
In initial experiments, both circular and linear DNA tem-
plates were used, and these were also biotinylated so that
displacement of RNAP could be monitored by examin-
ing the release of the transcript into the supernatant us-
ing a pulldown approach (Figure 4A). In the absence of
UvrD, the RNAP forms long transcripts indicative of pro-
cessive transcription elongation (Figure 4B; lanes 2, 3, 7
and 8). Shorter RNA transcripts are formed in a UvrD-
dependent manner regardless of whether the template is
circular or linear, and these transcripts generally remain
in the pellet fraction (Figure 4B). This is consistent with
UvrD causing backtracking of RNAP as reported previ-
ously (1), and this was confirmed by adding the transcript
cleavage factor GreB (which removes the extruding 3′ por-
tion of the nascent RNA) and then chasing the reaction
with NTPs to generate full length transcripts (Supplemen-
tary Figure S5, lanes 1–13, see figure legend for details). In
addition to backtracking, we also observed efficient UvrD-
dependent displacement of short RNA transcripts into the
supernatant, and this phenomenon was only observed with
the linear template (Figure 4B, see asterisks). Interestingly,
the size of these released transcripts is equivalent to the size
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Figure 3. Mutation of the PcrACTD reduces binding to RNAP. (A) Affin-
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trol: a measure of relative abundance of the prey. The enrichment of PcrA
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of the major GreB-cleavage products (Supplementary Fig-
ure S5, compare lanes 9 and 11), which are indicative of fa-
vored backtracking positions for RNAP on the template.
In the absence of UvrD, several transcripts that are longer
than the distance from the promoter to the end of the tem-
plate were observed. Such transcripts result from transfer
of RNAP from an end of one DNA molecule to an end of
another (67). Interestingly, addition of UvrD abolishes this
end-to-end transfer, possibly by backtracking RNAP away
from the DNA end, or by dissociating it from the DNA
altogether. Together, these experiments show that UvrD is
capable of remodeling transcription elongation complexes
in vitro, by promoting both the reversible backtracking of
RNAP, and the premature release of short RNA transcripts
from linear templates.
We next performed experiments on free linear template
DNA using mutant UvrD proteins in which the CTD was
either removed or mutated (Figure 5). The very strong con-
servation of primary sequence in the CTD (Supplementary
Figure S1) allows the facile design of mutations in E. coli
UvrD (UvrDCorUvrDK708A) that are equivalent to those
we have studied in PcrA. In the absence of UvrD, RNAP
transcribed the template DNA to produce products which
correspond to transcription to the end of the template (Fig-
ure 5A; lane 1 +60). As expected, in the presence of wild
type UvrD a series of shorter RNA transcripts were ob-
served (Figure 5A, compare lane 1 with lanes 2–5). This ef-
fect was UvrD dose-dependent, but less efficient than has
been reported previously (1). On these substrates, UvrD-
dependent RNAP remodelling was substantially reduced in
the absence of the CTD (Figure 5A and B, compare lanes
2–5 with lanes 6–9). However, it was still possible to observe
backtracking of RNAP on linear DNA templates using this
mutant, especially when bound to streptavidin coated mag-
netic beads (Supplementary Figure S5). The deletion of the
CTD is particularly effective at decreasing the premature re-
lease of RNA into solution that is observed on linear tem-
plates (Figure 5A and Supplementary Figure S5, see aster-
isks). Mutation of the highly conserved lysine in the CTD
(K708A) also reduced the remodeling ofRNAP-RNAcom-
plexes relative to wild type, albeit not to the same extent as
does the complete removal of the CTD (Figure 5A and B).
Together, these experiments indicate that the CTD is im-
portant but not essential for catalysing backtracking and
RNA release from RNAP during transcription in vitro. To
eliminate the possibility that the mutant proteins were sim-
ply unfolded, or that the observed remodeling defects re-
flected a reduced ability of the mutant proteins to move
along DNA we assayed for ATPase and DNA translocase
activity. These experiments showed that UvrD proteins in
which the CTD had been either mutated or deleted retained
ssDNA-dependent ATPase and translocase activities that
were either comparable to, or even better than, wild type
activity (Table 2 and Figure 5C). This is broadly consis-
tent with previous experiments on a UvrD protein with a 40
amino acid C-terminal deletion which displayed wild type
ATPase and helicase activity (68).
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DISCUSSION
Superfamily I helicases are highly abundant and often
multi-functional enzymes playing diverse roles in bacterial
nucleic acid metabolism. Interestingly, several recent stud-
ies have shown that these enzymes function at the interface
of DNA replication, transcription and repair. In rapidly di-
viding bacterial cells, the replication and transcription of
DNA occur on the same template at the same time. Con-
flicts between the two systems are inevitable and can lead
to genomic instability, and so cells have developed systems
that either reduce their occurrence or minimize their impact
(reviewed in (69)). For example, some Superfamily I heli-
cases have been shown to help the replisome bypass physical
barriers including transcription complexes in variousmodel
organisms. However, the mechanisms by which they do so
are only recently becoming apparent and may vary widely.
In E. coli, the SF1 helicases Rep, UvrD and DinG have
all been shown to resolve replication:transcription conflicts
(26,27,70). Rep functions as a component of the replisome
itself, by associating with the replicative helicase DnaB, and
loss of this interaction results in transcription:replication
conflicts (26,71). In distinct contrast, UvrD interacts di-
rectly with RNAP (1), and an equivalent interaction has
also been demonstrated in the orthologous PcrA enzyme
(14,21,72). However, recent work in B. subtilis shows that
deletion of the PcrACTDdoes not affect its essential role in
resolving replication:transcription conflicts, whereas elimi-
nation of its ATPase/helicase activity does (27). Although
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Figure 5. Mutation or removal of the CTD reduces UvrD-dependent remodeling of RNAP transcripts, but not DNA translocase activity. (A) Transcript
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perhaps surprising, this result is consistent with the long
standing observation that Rep and UvrD share an essen-
tial function in E. coli (73,74), despite the fact that Rep
does not interact with RNAP. Nevertheless, the extremely
high conservation of the PcrA/UvrD CTD region would
suggest either that there is some unappreciated complex-
ity in observing a phenotype associated with its deletion
and/or that it has a different role that is also (presumably)
related to transcription. Indeed, recent experiments have
suggested that UvrD can backtrack RNAP in vitro and in
vivo (1,2). We have shown here that this backtracking func-
tion is perturbed, albeit not entirely eliminated, by dele-
tion or mutation of the CTD. Therefore, this work poten-
tially identifies separation of function mutants that can be
used to study the backtracking role of PcrA/UvrD specifi-
cally (25). In this respect, it is interesting and important to
note that the loss of the PcrA/UvrD CTD has no appar-
ent effect on nucleotide excision repair, mismatch repair or
the resolution of transcription:replication conflicts in vivo
(see Supplementary Figure S6 and accompanying legend)
(15,27,68,75). This implies that efficient RNAP remodeling
is not important for any of these processes, at least in certain
circumstances. A key challenge for future experiments will
be to rationalise how the extreme multi-functionality dis-
played by helicases like PcrA/UvrD relates to the spectrum
of protein:protein interactions that they can form, and how
these different aspects of their function are regulated.
We have further defined the minimal RNAP polymerase
interaction domain in the C-terminal region using G.
stearothermophilus PcrA as a model system.We have shown
for the first time that this adopts a Tudor fold in common
with several other bacterial proteins involved in modulat-
ing transcription. Removal of the CTD of PcrA causes ei-
ther no reduction or a modest reduction in ATPase, heli-
case and translocase activity in vitro (14,32). A similar anal-
ysis of UvrD showed no change in translocase activity and
either no change or a moderate increase in ATPase (this
work and (15,68,75)) Moreover, our biochemical analysis
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shows that the isolated CTD of PcrA does not bind to ei-
ther single- or double-stranded DNA (Supplementary Fig-
ure S3). Therefore, despite the location of this domain in
the vicinity of the displaced strand during DNA unwind-
ing, it does not seem to be involved in directly stimulat-
ing helicase activity, and may even have an attenuating ef-
fect on the ATPase. Simple point mutations in the CTD
of PcrA greatly reduce RNAP binding but have no signifi-
cant effect on the ssDNA-dependent ATPase activity. These
mutations map to a well-conserved surface on the CTD of
PcrA/UvrD orthologues. It is noteworthy that the same re-
gion of the Tudor fold is frequently observed to be the in-
teraction interface for many other Tudor domains that are
quite diverse at the level of primary structure.Given that Tu-
dor domains arewell-characterized as readers ofmethylated
lysines in eukaryotic chromatin, a highly speculative possi-
bility is that PcrA/UvrDmight interact with RNAP follow-
ing post-translational modifications of lysines or arginines.
These are abundant in bacterial proteins including RNAP
but their function is usually unclear (76,77).
We do not know precisely where the CTD of PcrA/UvrD
engages RNAP. Two-hybrid data and far western blots have
suggested that the PcrA CTD contacts the N-terminal re-
gion (aa 1–400) of the  subunit (29). Given that related Tu-
dor domains inMfd and CarD/CdnL family proteins make
contact with the1 region (which is foundwithin aa 1–400),
an intriguing possibility is that PcrA/UvrD and Mfd com-
pete for the same interaction patch on RNAP. However, we
do not currently favor this possibility because we do not ob-
serve a dominant negative effect of the E. coli UvrD CTD
uponMfd function in vitro (data not shown). It is also quite
possible that the C-terminal Tudor domain is not the only
determinant of the RNAP interaction, and feasible that the
details of the interaction differ between the UvrD and PcrA
proteins studied here. Such factors would complicate the in-
terpretation of any phenotypic analysis, and might also ex-
plain why the PcrA/UvrDmutants used in this study retain
a limited ability to bind or backtrack RNA polymerase. In-
deed, far western blots have suggested that an additional
region in the N-terminus of PcrA is important for an in-
teraction with the ′ subunit of RNAP in B. subtilis (29).
Moreover, crosslinking experiments with E. coli UvrD and
RNAP also suggest an interface involving the N-terminal
helicase region (1). Further support for a more extensive
interface is provided by analogy with RapA. A structure
of RapA bound to RNAP shows that, although its Tudor
domains are important for the inter-protein interactions as
expected, the entire RapA protein including the core heli-
case regions also plays a role in the interactions (59). A final
complexity is that the interaction could be modulated by a
regulatory signal. For example, the ability of UvrD to back-
track RNAP has recently been shown to be enhanced by the
presence of the small molecule alarmone ppGpp: this effect
is likely due in part to changes in the properties of RNAP,
but may also reflect an altered interaction between UvrD
and RNAP (2). These questions will be the subject of fur-
ther study.
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